Skip to main content
Erschienen in: Current Treatment Options in Psychiatry 3/2015

01.09.2015 | Mood Disorders (S Frangou, Section Editor)

Staging Models and Functional Outcomes in Bipolar Disorder: Clinical Implications

verfasst von: Ives C. Passos, MD, Natália S. Kapczinski, PsyD, João Quevedo, MD, PhD, Márcia Kauer-Sant’Anna, MD, PhD, Flávio Kapczinski, MD, PhD

Erschienen in: Current Treatment Options in Psychiatry | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Opinion statement

Prognostic staging has been gaining traction in psychiatry in the past few years. The heterogeneity of clinical presentations in bipolar disorder has been an important challenge to clinicians and researchers. Staging models attempt to overcome this problem by identifying clusters of patients with bipolar disorder who have a differential course of illness and response to treatments. There is an emerging body of knowledge suggesting that staging models based on functional outcomes (functional staging) may provide clinicians with a useful tool to predict the course of illness and organize treatment strategies to individual patients. For instance, it has been widely accepted that earlier interventions in BD are likely to be associated with a better response to treatment, and lower rates of functional impairment. Also, while treatments such as lithium monotherapy, cognitive behavioral therapy, and psychoeducation seem to be better suited to prevent further recurrences within patients with few episodes, complex pharmacological strategies and functional remediation might be considered in more severe patients. Therefore, the aim of the present work is to review the evidence related to the clinical use of functional staging models in bipolar disorder.
Literatur
1.
Zurück zum Zitat Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543–52.PubMedCentralPubMedCrossRef Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543–52.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry. 2011;68(10):1058–64.PubMedCrossRef Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry. 2011;68(10):1058–64.PubMedCrossRef
3.
4.
Zurück zum Zitat Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152(11):1635–40.PubMedCrossRef Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152(11):1635–40.PubMedCrossRef
5.
Zurück zum Zitat Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov. 2007;6(4):287–93.PubMedCrossRef Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov. 2007;6(4):287–93.PubMedCrossRef
6.
Zurück zum Zitat Stinchcombe TE, Bogart JA. Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer. Oncologist. 2012;17(5):682–93.PubMedCentralPubMedCrossRef Stinchcombe TE, Bogart JA. Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer. Oncologist. 2012;17(5):682–93.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Fedele F, Severino P, Calcagno S, Mancone M. Heart failure: TNM-like classification. J Am Coll Cardiol. 2014;63(19):1959–60.PubMedCrossRef Fedele F, Severino P, Calcagno S, Mancone M. Heart failure: TNM-like classification. J Am Coll Cardiol. 2014;63(19):1959–60.PubMedCrossRef
8.
Zurück zum Zitat McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–22.PubMedCrossRef McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–22.PubMedCrossRef
9.
Zurück zum Zitat Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9(7):671–8.PubMedCrossRef Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9(7):671–8.PubMedCrossRef
10.
Zurück zum Zitat Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9(7):957–66.PubMedCrossRef Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9(7):957–66.PubMedCrossRef
11.
Zurück zum Zitat Duffy A, Alda M, Hajek T, Sherry SB, Grof P. Early stages in the development of bipolar disorder. J Affect Disord. 2010;121(1–2):127–35.PubMedCrossRef Duffy A, Alda M, Hajek T, Sherry SB, Grof P. Early stages in the development of bipolar disorder. J Affect Disord. 2010;121(1–2):127–35.PubMedCrossRef
12.
Zurück zum Zitat Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2013;82(1):20–34.PubMedCrossRef Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2013;82(1):20–34.PubMedCrossRef
13.
Zurück zum Zitat Rosa AR, Magalhães PVS, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75(5):e450–6.PubMedCrossRef Rosa AR, Magalhães PVS, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75(5):e450–6.PubMedCrossRef
14.
Zurück zum Zitat Reinares M, Papachristou E, Harvey P, Mar Bonnín C, Sánchez-Moreno J, Torrent C, et al. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord. 2013;144(1–2):65–71.PubMedCrossRef Reinares M, Papachristou E, Harvey P, Mar Bonnín C, Sánchez-Moreno J, Torrent C, et al. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord. 2013;144(1–2):65–71.PubMedCrossRef
15.•
Zurück zum Zitat Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804–17. An important review about the biological underpinnings of neuroprogression in bipolar disorder.PubMedCrossRef Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804–17. An important review about the biological underpinnings of neuroprogression in bipolar disorder.PubMedCrossRef
16.
Zurück zum Zitat Kapczinski F, Dias VV, Kauer-Sant’Anna M, Brietzke E, Vázquez GH, Vieta E, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1366–71.PubMedCrossRef Kapczinski F, Dias VV, Kauer-Sant’Anna M, Brietzke E, Vázquez GH, Vieta E, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1366–71.PubMedCrossRef
17.
Zurück zum Zitat Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res. 2010;18(3–4):256–71.PubMedCrossRef Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res. 2010;18(3–4):256–71.PubMedCrossRef
18.
Zurück zum Zitat Tohen M, Hennen J, Zarate CM, Baldessarini RJ, Strakowski SM, Stoll AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157(2):220–8.PubMedCrossRef Tohen M, Hennen J, Zarate CM, Baldessarini RJ, Strakowski SM, Stoll AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157(2):220–8.PubMedCrossRef
19.•
Zurück zum Zitat Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, et al. Stage managing bipolar disorder. Bipolar Disord. 2014;16(5):471–7. An important review about the treatments options based on staging models in bipolar disorder.PubMedCrossRef Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, et al. Stage managing bipolar disorder. Bipolar Disord. 2014;16(5):471–7. An important review about the treatments options based on staging models in bipolar disorder.PubMedCrossRef
20.
Zurück zum Zitat Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15(1):1–44.PubMedCrossRef Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15(1):1–44.PubMedCrossRef
21.
Zurück zum Zitat Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller H-J, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.PubMedCrossRef Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller H-J, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.PubMedCrossRef
22.
Zurück zum Zitat Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1–50. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1–50.
23.
Zurück zum Zitat Grande I, Magalhães PV, Chendo I, Stertz L, Panizutti B, Colpo GD, et al. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand. 2014;129(6):437–44.PubMedCrossRef Grande I, Magalhães PV, Chendo I, Stertz L, Panizutti B, Colpo GD, et al. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand. 2014;129(6):437–44.PubMedCrossRef
24.
Zurück zum Zitat Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010;71(9):1176–86. quiz 1252–3. Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010;71(9):1176–86. quiz 1252–3.
25.
Zurück zum Zitat Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):447–58.PubMedCrossRef Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):447–58.PubMedCrossRef
26.
Zurück zum Zitat Post RM, Kalivas P. Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry. 2013;202(3):172–6.PubMedCentralPubMedCrossRef Post RM, Kalivas P. Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry. 2013;202(3):172–6.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Kessing LV, Andersen PK. Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders. Curr Psychiatry Rep. 2005;7(6):413–20.PubMedCrossRef Kessing LV, Andersen PK. Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders. Curr Psychiatry Rep. 2005;7(6):413–20.PubMedCrossRef
28.
Zurück zum Zitat Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994–1999. Br J Psychiatry. 2004;185:372–7.PubMedCrossRef Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994–1999. Br J Psychiatry. 2004;185:372–7.PubMedCrossRef
29.
Zurück zum Zitat Magalhães PV, Dodd S, Nierenberg AA, Berk M. Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Aust N Z J Psychiatry. 2012;46(11):1058–67.PubMedCrossRef Magalhães PV, Dodd S, Nierenberg AA, Berk M. Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Aust N Z J Psychiatry. 2012;46(11):1058–67.PubMedCrossRef
30.
Zurück zum Zitat Kessing LV, Hansen HV, Christensen EM, Dam H, Gluud C, Wetterslev J. Do young adults with bipolar disorder benefit from early intervention? J Affect Disord. 2014;152–154:403–8.PubMedCrossRef Kessing LV, Hansen HV, Christensen EM, Dam H, Gluud C, Wetterslev J. Do young adults with bipolar disorder benefit from early intervention? J Affect Disord. 2014;152–154:403–8.PubMedCrossRef
31.•
Zurück zum Zitat Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006;188:313–20. An important study about cognitive behavioral therapy in patients with bipolar disorder and the differential response as a function of the severety of the disorder.PubMedCrossRef Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006;188:313–20. An important study about cognitive behavioral therapy in patients with bipolar disorder and the differential response as a function of the severety of the disorder.PubMedCrossRef
32.
Zurück zum Zitat Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156(8):1264–6.PubMed Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156(8):1264–6.PubMed
33.
Zurück zum Zitat Leverich GS, Post RM. Course of bipolar illness after history of childhood trauma. Lancet. 2006;367(9516):1040–2.PubMedCrossRef Leverich GS, Post RM. Course of bipolar illness after history of childhood trauma. Lancet. 2006;367(9516):1040–2.PubMedCrossRef
34.
Zurück zum Zitat Leverich GS, McElroy SL, Suppes T, Keck PE, Denicoff KD, Nolen WA, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51(4):288–97.PubMedCrossRef Leverich GS, McElroy SL, Suppes T, Keck PE, Denicoff KD, Nolen WA, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51(4):288–97.PubMedCrossRef
35.
Zurück zum Zitat Gershon A, Johnson SL, Miller I. Chronic stressors and trauma: prospective influences on the course of bipolar disorder. Psychol Med. 2013;43(12):2583–92.PubMedCrossRef Gershon A, Johnson SL, Miller I. Chronic stressors and trauma: prospective influences on the course of bipolar disorder. Psychol Med. 2013;43(12):2583–92.PubMedCrossRef
36.
Zurück zum Zitat Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, et al. Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder. Bipolar Disord. 2014 Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, et al. Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder. Bipolar Disord. 2014
37.
Zurück zum Zitat Hauser M, Galling B, Correll CU. Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions. Bipolar Disord. 2013;15(5):507–23.PubMedCentralPubMedCrossRef Hauser M, Galling B, Correll CU. Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions. Bipolar Disord. 2013;15(5):507–23.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Bahorik AL, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction. 2013;108(7):1259–69.PubMedCentralPubMedCrossRef Bahorik AL, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction. 2013;108(7):1259–69.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Masi G, Mucci M, Pfanner C, Berloffa S, Magazù A, Perugi G. Developmental pathways for different subtypes of early-onset bipolarity in youths. J Clin Psychiatry. 2012;73(10):1335–41.PubMedCrossRef Masi G, Mucci M, Pfanner C, Berloffa S, Magazù A, Perugi G. Developmental pathways for different subtypes of early-onset bipolarity in youths. J Clin Psychiatry. 2012;73(10):1335–41.PubMedCrossRef
40.
Zurück zum Zitat Neria Y, Olfson M, Gameroff MJ, Wickramaratne P, Pilowsky D, Verdeli H, et al. Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder. Bipolar Disord. 2008;10(4):503–10.PubMedCentralPubMedCrossRef Neria Y, Olfson M, Gameroff MJ, Wickramaratne P, Pilowsky D, Verdeli H, et al. Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder. Bipolar Disord. 2008;10(4):503–10.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Maguire C, McCusker CG, Meenagh C, Mulholland C, Shannon C. Effects of trauma on bipolar disorder: the mediational role of interpersonal difficulties and alcohol dependence. Bipolar Disord. 2008;10(2):293–302.PubMedCrossRef Maguire C, McCusker CG, Meenagh C, Mulholland C, Shannon C. Effects of trauma on bipolar disorder: the mediational role of interpersonal difficulties and alcohol dependence. Bipolar Disord. 2008;10(2):293–302.PubMedCrossRef
42.
Zurück zum Zitat Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry. 2013;70(9):931–9.PubMedCrossRef Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry. 2013;70(9):931–9.PubMedCrossRef
43.
Zurück zum Zitat Birmaher B, Gill MK, Axelson DA, Goldstein BI, Goldstein TR, Yu H, et al. Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders. Am J Psychiatry. 2014;171(9):990–9.PubMedCentralPubMedCrossRef Birmaher B, Gill MK, Axelson DA, Goldstein BI, Goldstein TR, Yu H, et al. Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders. Am J Psychiatry. 2014;171(9):990–9.PubMedCentralPubMedCrossRef
44.
Zurück zum Zitat Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675–92.PubMedCrossRef Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675–92.PubMedCrossRef
45.
Zurück zum Zitat Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74(1):15–25.PubMedCrossRef Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74(1):15–25.PubMedCrossRef
46.
Zurück zum Zitat Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010;15(4):384–92.PubMedCentralPubMedCrossRef Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010;15(4):384–92.PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Munkholm K, Braüner JV, Kessing LV, Vinberg M. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013;47(9):1119–33.PubMedCrossRef Munkholm K, Braüner JV, Kessing LV, Vinberg M. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013;47(9):1119–33.PubMedCrossRef
48.
Zurück zum Zitat Cunha ABM, Frey BN, Andreazza AC, Goi JD, Rosa AR, Gonçalves CA, et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett. 2006;398(3):215–9.PubMedCrossRef Cunha ABM, Frey BN, Andreazza AC, Goi JD, Rosa AR, Gonçalves CA, et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett. 2006;398(3):215–9.PubMedCrossRef
49.
Zurück zum Zitat Fernandes BS, Berk M, Turck CW, Steiner J, Gonçalves C-A. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry. 2014;19(7):750–1.PubMedCrossRef Fernandes BS, Berk M, Turck CW, Steiner J, Gonçalves C-A. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry. 2014;19(7):750–1.PubMedCrossRef
50.
Zurück zum Zitat Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014;218(1–2):61–8.PubMedCrossRef Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014;218(1–2):61–8.PubMedCrossRef
51.
Zurück zum Zitat Andreazza AC, Shao L, Wang J-F, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 2010;67(4):360–8.PubMedCrossRef Andreazza AC, Shao L, Wang J-F, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 2010;67(4):360–8.PubMedCrossRef
53.
Zurück zum Zitat Rizzo LB, Costa LG, Mansur RB, Swardfager W, Belangero SI, Grassi-Oliveira R, et al. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research. Neurosci Biobehav Rev. 2014;42:157–69.PubMedCrossRef Rizzo LB, Costa LG, Mansur RB, Swardfager W, Belangero SI, Grassi-Oliveira R, et al. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research. Neurosci Biobehav Rev. 2014;42:157–69.PubMedCrossRef
54.
Zurück zum Zitat Jurk D, Wilson C, Passos JF, Oakley F, Correia-Melo C, Greaves L, et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun. 2014;2:4172.PubMedCentralPubMedCrossRef Jurk D, Wilson C, Passos JF, Oakley F, Correia-Melo C, Greaves L, et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun. 2014;2:4172.PubMedCentralPubMedCrossRef
55.••
Zurück zum Zitat Frank E, Nimgaonkar VL, Phillips ML, Kupfer DJ. All the world’s a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry. 2014; A recent stage model for bipolar disorder based on neuroimging studies. Frank E, Nimgaonkar VL, Phillips ML, Kupfer DJ. All the world’s a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry. 2014; A recent stage model for bipolar disorder based on neuroimging studies.
56.
Zurück zum Zitat Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry. 2002;159(11):1841–7.PubMedCrossRef Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry. 2002;159(11):1841–7.PubMedCrossRef
57.
Zurück zum Zitat Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, et al. MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res. 35(6):313–22. Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, et al. MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res. 35(6):313–22.
58.
Zurück zum Zitat DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology. 1999;21(1):63–8.PubMedCrossRef DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology. 1999;21(1):63–8.PubMedCrossRef
59.
Zurück zum Zitat Haukvik UK, Westlye LT, Mørch-Johnsen L, Jørgensen KN, Lange EH, Dale AM, et al. In Vivo Hippocampal Subfield Volumes in Schizophrenia and Bipolar Disorder. Biol Psychiatry. 2014. Haukvik UK, Westlye LT, Mørch-Johnsen L, Jørgensen KN, Lange EH, Dale AM, et al. In Vivo Hippocampal Subfield Volumes in Schizophrenia and Bipolar Disorder. Biol Psychiatry. 2014.
60.
Zurück zum Zitat Vita A, De Peri L, Sacchetti E. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord. 2009;11(8):807–14.PubMedCrossRef Vita A, De Peri L, Sacchetti E. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord. 2009;11(8):807–14.PubMedCrossRef
61.
Zurück zum Zitat Bora E, Fornito A, Yücel M, Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry. 2010;67(11):1097–105.PubMedCrossRef Bora E, Fornito A, Yücel M, Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry. 2010;67(11):1097–105.PubMedCrossRef
62.
Zurück zum Zitat Kalmar JH, Wang F, Spencer L, Edmiston E, Lacadie CM, Martin A, et al. Preliminary evidence for progressive prefrontal abnormalities in adolescents and young adults with bipolar disorder. J Int Neuropsychol Soc. 2009;15(3):476–81.PubMedCentralPubMedCrossRef Kalmar JH, Wang F, Spencer L, Edmiston E, Lacadie CM, Martin A, et al. Preliminary evidence for progressive prefrontal abnormalities in adolescents and young adults with bipolar disorder. J Int Neuropsychol Soc. 2009;15(3):476–81.PubMedCentralPubMedCrossRef
63.
Zurück zum Zitat Gogtay N, Ordonez A, Herman DH, Hayashi KM, Greenstein D, Vaituzis C, et al. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J Child Psychol Psychiatry. 2007;48(9):852–62.PubMedCrossRef Gogtay N, Ordonez A, Herman DH, Hayashi KM, Greenstein D, Vaituzis C, et al. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J Child Psychol Psychiatry. 2007;48(9):852–62.PubMedCrossRef
64.
Zurück zum Zitat Lisy ME, Jarvis KB, DelBello MP, Mills NP, Weber WA, Fleck D, et al. Progressive neurostructural changes in adolescent and adult patients with bipolar disorder. Bipolar Disord. 2011;13(4):396–405.PubMedCrossRef Lisy ME, Jarvis KB, DelBello MP, Mills NP, Weber WA, Fleck D, et al. Progressive neurostructural changes in adolescent and adult patients with bipolar disorder. Bipolar Disord. 2011;13(4):396–405.PubMedCrossRef
65.
Zurück zum Zitat Yucel K, McKinnon MC, Taylor VH, Macdonald K, Alda M, Young LT, et al. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology (Berl). 2007;195(3):357–67.CrossRef Yucel K, McKinnon MC, Taylor VH, Macdonald K, Alda M, Young LT, et al. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology (Berl). 2007;195(3):357–67.CrossRef
66.
Zurück zum Zitat Hajek T, Kopecek M, Höschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci. 2012;37(5):333–43.PubMedCentralPubMedCrossRef Hajek T, Kopecek M, Höschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci. 2012;37(5):333–43.PubMedCentralPubMedCrossRef
67.
Zurück zum Zitat Hajek T, Cullis J, Novak T, Kopecek M, Höschl C, Blagdon R, et al. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord. 2012;14(3):261–70.PubMedCentralPubMedCrossRef Hajek T, Cullis J, Novak T, Kopecek M, Höschl C, Blagdon R, et al. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord. 2012;14(3):261–70.PubMedCentralPubMedCrossRef
68.
Zurück zum Zitat Rosa AR, Franco C, Martínez-Aran A, Sánchez-Moreno J, Reinares M, Salamero M, et al. Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom. 2008;77(6):390–2.PubMedCrossRef Rosa AR, Franco C, Martínez-Aran A, Sánchez-Moreno J, Reinares M, Salamero M, et al. Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom. 2008;77(6):390–2.PubMedCrossRef
69.
Zurück zum Zitat Goldstein TR, Birmaher B, Axelson D, Goldstein BI, Gill MK, Esposito-Smythers C, et al. Psychosocial functioning among bipolar youth. J Affect Disord. 2009;114(1–3):174–83.PubMedCentralPubMedCrossRef Goldstein TR, Birmaher B, Axelson D, Goldstein BI, Gill MK, Esposito-Smythers C, et al. Psychosocial functioning among bipolar youth. J Affect Disord. 2009;114(1–3):174–83.PubMedCentralPubMedCrossRef
70.
Zurück zum Zitat Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 9(1–2):183–96. Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 9(1–2):183–96.
71.
Zurück zum Zitat Martínez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sánchez-Moreno J, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262–70.PubMedCrossRef Martínez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sánchez-Moreno J, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262–70.PubMedCrossRef
72.
Zurück zum Zitat Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh JTO, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013;128(3):149–62.PubMedCrossRef Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh JTO, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013;128(3):149–62.PubMedCrossRef
73.
Zurück zum Zitat DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164(4):582–90.PubMedCrossRef DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164(4):582–90.PubMedCrossRef
74.
Zurück zum Zitat Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord. 9(1–2):93–102. Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord. 9(1–2):93–102.
75.
Zurück zum Zitat Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord. 2008;109(3):286–99.PubMedCrossRef Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord. 2008;109(3):286–99.PubMedCrossRef
76.
Zurück zum Zitat Martino DJ, Igoa A, Marengo E, Scápola M, Strejilevich SA. Neurocognitive impairments and their relationship with psychosocial functioning in euthymic bipolar II disorder. J Nerv Ment Dis. 2011;199(7):459–64.PubMedCrossRef Martino DJ, Igoa A, Marengo E, Scápola M, Strejilevich SA. Neurocognitive impairments and their relationship with psychosocial functioning in euthymic bipolar II disorder. J Nerv Ment Dis. 2011;199(7):459–64.PubMedCrossRef
77.
Zurück zum Zitat Duffy A, Alda M, Crawford L, Milin R, Grof P. The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar parents. Bipolar Disord. 2007;9(8):828–38.PubMedCrossRef Duffy A, Alda M, Crawford L, Milin R, Grof P. The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar parents. Bipolar Disord. 2007;9(8):828–38.PubMedCrossRef
78.
Zurück zum Zitat Berger GE, Wood SJ, Ross M, Hamer CA, Wellard RM, Pell G, et al. Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. Curr Pharm Des. 2012;18(4):570–5.PubMedCrossRef Berger GE, Wood SJ, Ross M, Hamer CA, Wellard RM, Pell G, et al. Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. Curr Pharm Des. 2012;18(4):570–5.PubMedCrossRef
79.
Zurück zum Zitat Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67(2):146–54.PubMedCrossRef Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67(2):146–54.PubMedCrossRef
80.
Zurück zum Zitat Nadkarni RB, Fristad MA. Clinical course of children with a depressive spectrum disorder and transient manic symptoms. Bipolar Disord. 2010;12(5):494–503.PubMedCentralPubMedCrossRef Nadkarni RB, Fristad MA. Clinical course of children with a depressive spectrum disorder and transient manic symptoms. Bipolar Disord. 2010;12(5):494–503.PubMedCentralPubMedCrossRef
81.
Zurück zum Zitat Miklowitz DJ, Chang KD, Taylor DO, George EL, Singh MK, Schneck CD, et al. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011;13(1):67–75.PubMedCentralPubMedCrossRef Miklowitz DJ, Chang KD, Taylor DO, George EL, Singh MK, Schneck CD, et al. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011;13(1):67–75.PubMedCentralPubMedCrossRef
82.
Zurück zum Zitat Macneil CA, Hallam K, Conus P, Henry L, Kader L, Berk M. Are we missing opportunities for early intervention in bipolar disorder? Expert Rev Neurother. 2012;12(1):5–7.PubMedCrossRef Macneil CA, Hallam K, Conus P, Henry L, Kader L, Berk M. Are we missing opportunities for early intervention in bipolar disorder? Expert Rev Neurother. 2012;12(1):5–7.PubMedCrossRef
83.
Zurück zum Zitat Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry. 2014;205(3):214–20.PubMedCrossRef Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry. 2014;205(3):214–20.PubMedCrossRef
84.
Zurück zum Zitat Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010;123(1–3):81–6.PubMedCrossRef Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010;123(1–3):81–6.PubMedCrossRef
85.••
Zurück zum Zitat Torrent C, del Bonnin CM, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170(8):852–9. An important clinical trial about the use of functional remediation in patients with bipolar disorder and functional impairment.PubMedCrossRef Torrent C, del Bonnin CM, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170(8):852–9. An important clinical trial about the use of functional remediation in patients with bipolar disorder and functional impairment.PubMedCrossRef
86.
Zurück zum Zitat Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry. 2000;61(1):9–15.PubMedCrossRef Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry. 2000;61(1):9–15.PubMedCrossRef
87.
Zurück zum Zitat González Isasi A, Echeburúa E, Limiñana JM, González-Pinto A. Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder: a 5-year controlled clinical trial. Eur Psychiatry. 2014;29(3):134–41.PubMedCrossRef González Isasi A, Echeburúa E, Limiñana JM, González-Pinto A. Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder: a 5-year controlled clinical trial. Eur Psychiatry. 2014;29(3):134–41.PubMedCrossRef
88.••
Zurück zum Zitat Li X-B, Tang Y-L, Wang C-Y, de Leon J. Clozapine for treatment-resistant bipolar disorder: a systematic review. Bipolar Disord. 2014. An important sytematic review about the use of clozapine in patients with treatment-resistant bipolar disorder. Li X-B, Tang Y-L, Wang C-Y, de Leon J. Clozapine for treatment-resistant bipolar disorder: a systematic review. Bipolar Disord. 2014. An important sytematic review about the use of clozapine in patients with treatment-resistant bipolar disorder.
89.
Zurück zum Zitat Murch S, Tran N, Liew D, Petrakis M, Prior D, Castle D. Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience. Aust Psychiatry. 2013;21(3):258–61.CrossRef Murch S, Tran N, Liew D, Petrakis M, Prior D, Castle D. Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience. Aust Psychiatry. 2013;21(3):258–61.CrossRef
90.
Zurück zum Zitat Nooijen PMM, Carvalho F, Flanagan RJ. Haematological toxicity of clozapine and some other drugs used in psychiatry. Hum Psychopharmacol. 2011;26(2):112–9.PubMedCrossRef Nooijen PMM, Carvalho F, Flanagan RJ. Haematological toxicity of clozapine and some other drugs used in psychiatry. Hum Psychopharmacol. 2011;26(2):112–9.PubMedCrossRef
91.
Zurück zum Zitat Flanagan RJ. Side effects of clozapine and some other psychoactive drugs. Curr Drug Saf. 2008;3(2):115–22.PubMedCrossRef Flanagan RJ. Side effects of clozapine and some other psychoactive drugs. Curr Drug Saf. 2008;3(2):115–22.PubMedCrossRef
92.
Zurück zum Zitat Anaya C, Martinez Aran A, Ayuso-Mateos JL, Wykes T, Vieta E, Scott J. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord. 2012;142(1–3):13–21.PubMedCrossRef Anaya C, Martinez Aran A, Ayuso-Mateos JL, Wykes T, Vieta E, Scott J. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord. 2012;142(1–3):13–21.PubMedCrossRef
93.
Zurück zum Zitat Bowie CR, Gupta M, Holshausen K. Cognitive remediation therapy for mood disorders: rationale, early evidence, and future directions. Can J Psychiatry. 2013;58(6):319–25.PubMed Bowie CR, Gupta M, Holshausen K. Cognitive remediation therapy for mood disorders: rationale, early evidence, and future directions. Can J Psychiatry. 2013;58(6):319–25.PubMed
94.
Zurück zum Zitat Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, et al. RESEARCH: cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010;16(5):298–307.PubMedCentralPubMedCrossRef Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, et al. RESEARCH: cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010;16(5):298–307.PubMedCentralPubMedCrossRef
95.
Zurück zum Zitat Spaulding WD, Reed D, Sullivan M, Richardson C, Weiler M. Effects of cognitive treatment in psychiatric rehabilitation. Schizophr Bull. 1999;25(4):657–76.PubMedCrossRef Spaulding WD, Reed D, Sullivan M, Richardson C, Weiler M. Effects of cognitive treatment in psychiatric rehabilitation. Schizophr Bull. 1999;25(4):657–76.PubMedCrossRef
96.
Zurück zum Zitat Naismith SL, Redoblado-Hodge MA, Lewis SJG, Scott EM, Hickie IB. Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach. J Affect Disord. 2010;121(3):258–62.PubMedCrossRef Naismith SL, Redoblado-Hodge MA, Lewis SJG, Scott EM, Hickie IB. Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach. J Affect Disord. 2010;121(3):258–62.PubMedCrossRef
97.
Zurück zum Zitat Ueland T, Rund BR. Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatr Scand. 2005;111(3):193–201.PubMedCrossRef Ueland T, Rund BR. Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatr Scand. 2005;111(3):193–201.PubMedCrossRef
98.
Zurück zum Zitat McGurk SR, Mueser KT, DeRosa TJ, Wolfe R. Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophr Bull. 2009;35(2):319–35.PubMedCentralPubMedCrossRef McGurk SR, Mueser KT, DeRosa TJ, Wolfe R. Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophr Bull. 2009;35(2):319–35.PubMedCentralPubMedCrossRef
99.
Zurück zum Zitat McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. Am J Psychiatry. 2007;164(3):437–41.PubMedCrossRef McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. Am J Psychiatry. 2007;164(3):437–41.PubMedCrossRef
100.
Zurück zum Zitat Martínez-Arán A, Torrent C, Solé B, Bonnín CM, Rosa AR, Sánchez-Moreno J, et al. Functional remediation for bipolar disorder. Clin Pract Epidemiol Ment Health. 2011;7:112–6.PubMedCentralPubMedCrossRef Martínez-Arán A, Torrent C, Solé B, Bonnín CM, Rosa AR, Sánchez-Moreno J, et al. Functional remediation for bipolar disorder. Clin Pract Epidemiol Ment Health. 2011;7:112–6.PubMedCentralPubMedCrossRef
101.
Zurück zum Zitat Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, et al. Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol. 2014. Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, et al. Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol. 2014.
Metadaten
Titel
Staging Models and Functional Outcomes in Bipolar Disorder: Clinical Implications
verfasst von
Ives C. Passos, MD
Natália S. Kapczinski, PsyD
João Quevedo, MD, PhD
Márcia Kauer-Sant’Anna, MD, PhD
Flávio Kapczinski, MD, PhD
Publikationsdatum
01.09.2015
Verlag
Springer International Publishing
Erschienen in
Current Treatment Options in Psychiatry / Ausgabe 3/2015
Elektronische ISSN: 2196-3061
DOI
https://doi.org/10.1007/s40501-015-0046-5

Weitere Artikel der Ausgabe 3/2015

Current Treatment Options in Psychiatry 3/2015 Zur Ausgabe

Substance Use Disorders (FG Moeller, Section Editor)

Gender Considerations in Addiction: Implications for Treatment

Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)

Neuromodulation Treatments for Schizophrenia

Child and Adolescent Psychiatry (M DelBello, Section Editor)

Pharmacotherapy for Adolescents with Substance Use Disorders

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.